Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a large increase in short interest in May. As of May 31st, there was short interest totalling 495,600 shares, an increase of 21.2% from the May 15th total of 408,800 shares. Based on an average daily volume of 504,400 shares, the days-to-cover ratio is […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Currently, 0.9% of the shares of the company are short sold. Based on […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 408,800 shares, a drop of 56.0% from the April 30th total of 930,000 shares. Based on an average trading volume of 514,400 shares, the […]
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) – Stock analysts at Wedbush boosted their Q2 2023 earnings per share (EPS) estimates for Magenta Therapeutics in a research report issued on Tuesday, May 16th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.19) for the quarter, up from their […]